News

page 1 of 3

Cuomo Announces Companies Partnering with UB

WBEN AM 930 in Buffalo, NY, reports on the STARTUP NY announcement, a five-year, $10 million effort to spur innovation in the upstate NY area. Appistry is one of the […]

Appistry Competition to Reward Creative Solutions for NGS Analysis

Clinical Lab Products covers the Appistry Pipeline Challenge competition.

Genomics Testing in Action: An Interview with Kevin Haar, CEO, Appistry

News-Medical.net interviews Appistry’s Kevin Haar about Appistry’s new CloudDx genomics testing service.

The Value of Present and Promise of Future Sequencing Strategies

Appistry’s Rich Mazzarella discusses the future of sequencing and how whole-genome and exome sequencing may contribute to making genomics testing routine in this commentary in Clinical Omics.

Appistry Seeks Submissions for NGS Analysis Pipeline Challenge

Uduak Thomas of BioInform interviews Kevin Haar and Rich Mazzarella about the Appistry Pipeline Challenge.

Genetic Testing in the Cloud

David Raths, contributing editor at Healthcare Informatics, interviews Ray Tait, Ph.D., vice president of research at Saint Louis University, about efforts at Saint Louis University to learn more about the […]

Appistry Begins Early Access for Cloud-based Genomic Test Ordering Service Ahead of Q2 Launch

Uduak Thomas interviews Appistry’s Trevor Heritage, VP of corporate development and strategy, about the early-access availability of Appistry CloudDx, a cloud-based genomic test ordering service.

Why Big Data Isn’t the Big Problem for Genomic Medicine

In this opinion piece, Michael Groner, VP engineering and chief architect, and Trevor Heritage, VP of corporate development and strategy, explain that the barriers to precision medicine aren’t technological, but […]

Big data firm to help NIH’s Undiagnosed Disease Program commercialize its genetic analysis techniques

Appistry CEO Kevin Haar and William Gahl, director the NIH Undiagnosed Diseases Program, explain to Deanna Pogorelc discuss how scaling the NIH UDP diploid aligner pipeline will assist in identifying […]

Appistry to Commercialize Informatics Pipeline, Provide Analysis Services for NIH’s Rare Diseases Program

Uduak Thomas interviews Appistry CEO Kevin Haar and William Gahl and Cornelius Boerkoel of the NIH Undiagnosed Diseases Program about their partnership to commercialize the NIH UDP’s diploid aligner pipeline.

Appistry to Build Out, Support NIH Rare Disease Exome Pipeline

Appistry CEO Kevin Haar and William Gahl, director the NIH Undiagnosed Diseases Program, spoke to Allison Proffitt about the joint effort to develop and deliver a pipeline that considers family […]

Bio-IT World interviews Appistry’s Trevor Heritage

Bio-IT World interviews Appistry’s Trevor Heritage about the addition of ContEst to the Cancer Genome Analysis Suite.